Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

98.62
+1.851.91%
Volume:525.94K
Turnover:52.37M
Market Cap:6.79B
PE:-31.64
High:100.85
Open:97.69
Low:97.21
Close:96.77
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:1.10
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:65.94
PE(LYR):-31.71

Loading ...

Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Oct 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Jul 11, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities